The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: -0.25 (-0.78%)
Spread: 0.50 (1.587%)
Open: 31.75
High: 31.75
Low: 31.75
Prev. Close: 32.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of EGM and Issue of £17.5 million of Equity

30 Oct 2019 13:55

RNS Number : 6704R
Duke Royalty Limited
30 October 2019
 

 

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Result of EGM and Issue of £17.5 million of Equity

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, announces that the Extraordinary Resolution put to Shareholders in connection with the Fundraising was duly passed at the General Meeting held earlier today. The voting results of the General Meeting will be available to view on the Company's website shortly at www.dukeroyalty.com.

The Company is pleased to confirm it has raised an additional £892,287 by way of Open Offer, as it received final valid applications from Qualifying Shareholders in respect of 2,027,925 Open Offer Shares including applications under the Excess Application Facility.

Accordingly, the Company has raised a total of approximately £17.45 million (before expenses) via the Fundraising, following the issue and allotment of 39,667,899 new ordinary shares (the Fundraising Shares"), comprising 36,591,000 Placing Shares, 2,027,925 Open Offer Shares and 1,048,974 Retail Offer Shares. An application has been made for the Fundraising Shares to be admitted to trading on AIM (Admission), which is expected to take place at 8.00 a.m. on 31 October 2019.

Directors' participation in the Fundraise

Name

No. of existing Ordinary Shares

No. of Placing Shares

Total holding

Percentage ofenlarged issuedshare capitalfollowingAdmission

Neil Johnson (1)

3,507,193

142,807

3,650,000

1.52

Charles Cannon-Brookes (2)

5,400,000

 

156,693

5,556,693

2.32

 

Justin Cochrane

740,000

75,000

815,000

0.34

 

(1) Of these, prior to the Fundraising 1,800,193 Ordinary Shares are legally owned by Abingdon Capital Corporation ("Abingdon"). Abingdon has not subscribed for any New Shares in the Fundraising. Mr Johnson is Abingdon's sole voting shareholder. Following the issue of New Shares, Abingdon will legally own 1,800,193 Ordinary Shares on Admission. Mr Johnson has subscribed in his own name for 142,807 New Shares, representing £62,835 in the Fundraising.

(2) Of these, prior to the Fundraising 2,500,000 Ordinary Shares are legally owned by Arlington Group Asset Management ("Arlington"). Arlington has subscribed for 156,693 New Shares, representing £68,945 in the Fundraising. Mr Cannon-Brookes is the investment director of Arlington and holds 40.27 percent of the voting shares of Arlington. Following the issue of New Shares, Arlington will legally own 2,656,693 Ordinary Shares on Admission.

Neil Johnson, CEO of Duke Royalty, said:

"We would like to thank our shareholders for the strong show of support in the Open Offer as well as welcome new investors onto our register as a result of the institutional Placing and Retail Offer. The strong uptake we have experienced through this Open Offer is very pleasing and shows continued support for our strategy to become the leading corporate royalty provider in the UK and Europe. With numerous follow-on and new royalty opportunities in the pipeline, we look forward to deploying the additional capital and in turn, enhancing the robust, predictable, long term returns we have demonstrated for shareholders."

Following Admission, the Company's issued ordinary share capital will comprise 239,540,358 ordinary shares of nil par value, of which none are held in treasury. The above figure of 239,540,358 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, capitalised terms shall have the meaning as those set out in the 'Definitions' section of the announcement issued by the Company on 4 October 2019.

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes

 

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser and Broker)

 

Julian Morse / Michael Johnson / Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

Edison Investment Research Limited

 

Elliot Berstock

+44 (0) 20 3077 5700

Newgate Communications

(PR)

Elisabeth Cowell/ Ian Silvera/ Megan Kovach

+44 (0) 20 3757 6882

PrimaryBid Limited

Kieran D'Silva

+44 (0) 207 491 6519

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMBJTMBAJBTL
Date   Source Headline
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing
31st Mar 20214:32 pmRNSPrimaryBid Offer
31st Mar 20214:30 pmRNSPlacing to raise a minimum of £30 million
31st Mar 20214:30 pmRNSExit of Investment into Royalty Partner
18th Mar 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
15th Mar 20217:00 amRNSIncreased £35 Million Revolving Credit Facility
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20212:05 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSFollow-on investment into existing royalty partner
19th Feb 20217:00 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSNew Royalty Partner
9th Feb 20212:36 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSTrading Update
22nd Jan 202111:44 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSFollow-on investment into existing Royalty Partner
11th Jan 20217:00 amRNSAppointment of Chief Investment Officer
24th Dec 20207:00 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:01 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:00 amRNSExit of Investment in Royalty Partner
9th Dec 20207:01 amRNSInterim Results
9th Dec 20207:00 amRNSReinstated Cash Dividend and Dividend Declaration
18th Nov 20207:01 amRNSInvestor Presentation
18th Nov 20207:00 amRNSNotice of Interim Results
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update and Reinstatement of Cash Dividend
21st Oct 20202:34 pmRNSResult of Annual General Meeting
21st Oct 20207:00 amRNSAppointment of Joint Broker
15th Oct 20205:35 pmRNSHolding(s) in Company
14th Oct 20201:00 pmRNSDirector/PDMR Dealings
2nd Oct 20203:47 pmRNSIssue of Equity for Scrip Dividend
2nd Oct 202012:39 pmRNSLTIP, Issue of Equity, Director/PDMR Holdings
1st Oct 20201:25 pmRNSScrip Dividend Reference Price
25th Sep 20207:00 amRNSPosting of Report and Accounts and Notice of AGM
17th Sep 20207:01 amRNSFinancial 2020 Final Results
17th Sep 20207:00 amRNSDividend Declaration
16th Sep 20207:00 amRNSTrading Update
14th Sep 20207:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSFollow-on investment into existing royalty partner
6th Aug 20207:00 amRNSTrading Update and Notice of FY 2020 Results
5th Aug 20205:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.